In contrast, physiological transient activation of NRF2 induced by DEM treatment elevated the canonical NRF2 targets NQO1 and GCLM but not NOTCH3 in NRF2-normal NSCLC cells (Fig. 4c). This evidence concerns the gene NOTCH3 and non-small cell lung carcinoma.